JRJack Ross

Jack Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jack Ross has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and implementation of a natural language processing system at the point of care: MiADE (Medical information AI Data Extractor)

    by Jennifer Jiang-Kells, James Brandreth, Leilei Zhu, Jack Ross, Yogini Jani, Enrico Costanza, Maisarah Amran, Zeljko Kraljevic, Xi Bai, Roberto Cresta, et al.

    Background: Well-organised electronic health records (EHR) are essential for high quality patient care, but EHR user interfaces can be cumbersome for entry of structured information, resulting in the majority of information being in free text rather than a structured form. This makes it difficult to retrieve information for clinical purposes and limits the research potential of the data. Natural language processing (NLP) at the point of care has been suggested as a way of improving data quality and completeness, but there is little evidence as to its effectiveness. We sought to generate such evidence by developing an open source, modular, configurable NLP system called MiADE, which is designed to integrate with an EHR. This paper describes the design of MiADE and the deployment at University College London Hospitals (UCLH), and is intended to benefit those who may wish to develop or implement a similar system elsewhere. Results: The MiADE system includes components to extract diagnoses, medications and allergies from a clinical note, and communicate with an EHR system in real time using Health Level 7 Clinical Document Architecture (HL7 CDA) messaging. This enables NLP results to be displayed to a clinician for verification before saving them to the patient's record. MiADE utilises the MedCAT library (part of the Cogstack family of NLP tools) for named entity recognition (NER) and linking to SNOMED CT, as well as context detection. MedCAT models underwent unsupervised and supervised training on patient notes from UCLH, achieving precision of 83.2% (95% CI 77.0, 88.1), and recall of 85.2% (95% CI 79.1, 89.8) for detection of diagnosis concepts. In simulation testing we found that MiADE reduced the time taken for clinicians to enter structured problem lists by 89%. We have commenced a trial implementation of MiADE at UCLH in live clinical use, integrated with the Epic EHR at UCLH. Conclusions: We have developed an open source point of care NLP system called MiADE and successfully integrated it with a live EHR at a major hospital for an evaluation study.


  • Open Access

    Beyond regulatory compliance: evaluating radiology artificial intelligence applications in deployment

    by J. Ross, S. Hammouche, Y. Chen, A.G. Rockall, S. Alabed, M. Chen, K. Dwivedi, D. Fascia, R. Greenhalgh, M. Hall, et al.


  • Artificial intelligence and machine learning for clinical pharmacology

    by David K. Ryan, Rory H. Maclean, Alfred Balston, Andrew Scourfield, Anoop D. Shah, Jack Ross

    Artificial intelligence (AI) will impact many aspects of clinical pharmacology, including drug discovery and development, clinical trials, personalized medicine, pharmacogenomics, pharmacovigilance and clinical toxicology. The rapid progress of AI in healthcare means clinical pharmacologists should have an understanding of AI and its implementation in clinical practice. As with any new therapy or health technology, it is imperative that AI tools are subject to robust and stringent evaluation to ensure that they enhance clinical practice in a safe and equitable manner. This review serves as an introduction to AI for the clinical pharmacologist, highlighting current applications, aspects of model development and issues surrounding evaluation and deployment. The aim of this article is to empower clinical pharmacologists to embrace and lead on the safe and effective use of AI within healthcare.


  • Open Access

    AI and machine learning for clinical pharmacology: A Primer

    by David Ryan, Rory Maclean, Alfred Balston, Andrew Scourfield, Anoop Shah, Jack Ross

    Artificial intelligence (AI) will impact many aspects of clinical pharmacology including drug discovery and development, clinical trials, personalised medicine, pharmacogenomics, pharmacovigilance and clinical toxicology. The rapid progress of AI in healthcare means clinical pharmacologists should have an understanding of AI and its implementation into clinical practice. As with any new therapy or health technology, it is imperative that AI tools are subject to robust and stringent evaluation to ensure that they enhance clinical practice in a safe and equitable manner. This review serves as an introduction to AI for the clinical pharmacologist, highlighting current applications, aspects of model development and issues surrounding evaluation and deployment. The aim of this article is to empower clinical pharmacologists to embrace and lead on the safe and effective use of AI within healthcare.